About: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1968

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1968 (uk) im Juni 1968 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1968 (ast) scientific article published on 01 June 1968 (en)
publication date	wds:Q70086060-07D46736-A59D-48ED-A531-D84CCCD4A098
publication date	1968-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70086060-54A3059B-DCAA-48C0-B708-3663DDEEF8D6
language of work or name	English
cites work	wds:Q70086060-385EA437-A085-4419-82F1-D1D1638884F3 wds:Q70086060-89284EBC-FF3D-4CED-9197-A328B153D9E4 wds:Q70086060-A3F24530-5642-46C6-8685-E525FF0C9BFD wds:Q70086060-B05C71CD-B6EC-405C-B363-432169F2700C wds:Q70086060-E11A3DE0-2E94-4FFB-8D81-A66F351B6585 wds:Q70086060-F9A5BFCB-0A62-4C97-BD8B-C86067A821B3
cites work	DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis The effect of barbiturates in patients with liver disease Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease Imperfection: biochemical phobias and metabolic ambivalence
author name string	wds:Q70086060-15C9149B-914A-4356-8A72-FC8B17EFB5B9 wds:Q70086060-C2A510C3-6DF7-4777-9F41-3F112AEF29F0 wds:Q70086060-D37A6710-E427-4997-9E08-FBCDA0AD411D
author name string	D Walker S Sherlock A J Levi
rdfs:label	Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (en) Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (nl)
skos:prefLabel	Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (en) Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (nl)
name	Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (en) Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (nl)
title	wds:Q70086060-8555C494-A832-47B8-AEC6-0E938FD77D76
title	Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy (en)
page(s)	wds:Q70086060-1D4AF781-7B18-4E8E-BDCE-D8E34CA3E3F6
page(s)	1275-1279
instance of	wds:Q70086060-BE569C47-377C-440E-8A15-B7012E86BC65
instance of	scholarly article
main subject	wds:Q70086060-4B3AFDDF-6D65-4B82-86DE-B38C330CF5AE wds:Q70086060-6D1C09D4-B427-4368-BA6D-0138A9888B12
main subject	liver disease isoniazid
PubMed ID	wds:Q70086060-E22166AB-66FF-40B0-9BE7-98E75175160C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4172137
PubMed ID	4172137
published in	wds:Q70086060-232EC944-3EC4-4E27-900A-B246584238E3
published in	The Lancet
issue	wds:Q70086060-6103BC75-2E8F-47D4-A4A8-5AF2414FCE4C
volume	wds:Q70086060-E797A716-B0AA-4467-B936-3B29B8E864D2
issue	7555
volume	1
DOI	wds:Q70086060-226C33B4-8F73-4E93-BD2D-19B8BF42D366
DOI	http://dx.doi.org/10.1016/S0140-6736(68)92292-7
DOI	10.1016/S0140-6736(68)92292-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70086060
is cites work of	Intravenous administration of diazepam in patients with chronic liver disease The role of the liver in drug metabolism Determination of drug metabolizing enzymes in needle biopsies of human liver Pharmacogenetics of cytochromes P450. Clinical Pharmacokinetics of Isoniazid Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update Ethnic differences in drug disposition and responsiveness Pharmacokinetic interactions with antiepileptic drugs Altered Hepatic Blood Flow and Drug Disposition1 Protein Binding and Kinetics of Drugs in Liver Diseases The effects of age and liver disease on the disposition and elimination of diazepam in adult man Determinants of serum antipyrine half-lives in patients with liver disease Clinical pharmacokinetics of the antituberculosis drugs The effect of cirrhosis of the liver on microsomal detoxications and cytochrome P-450 Antiepileptic drugs. A review of clinically significant drug interactions. Decreased first-pass metabolism of labetalol in chronic liver disease Survey of the human acetylator polymorphism in spontaneous disorders Pathophysiological Factors Influencing Drug Kinetics Determinants of the response to coumarin anticoagulants in patients with acute myocardial infarction Impaired oxidation of debrisoquine in patients with perhexiline neuropathy Clinical Pharmacokinetics of Phenylbutazone Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis Drug Prescribing in Hepatobiliary Disease Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs Effects of ethanol upon lipid metabolism Influences of diet and nutrition on clinical pharmacokinetics A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Altered elimination of antipyrine in patients with acute viral hepatitis Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy Metabolism of amylobarbitone in patients with chronic liver disease Liver disease and drug therapy Anticonvulsant drugs. An update Genetic Control of Phenylbutazone Metabolism in Man The absorption and metabolism in rats of small oral doses of dimethylnitrosamine. Implication for the possible hazard of dimethylnitrosamine in human food Psychological Effects Caused by Drugs in Overdose Interactions with Antiepileptic Drugs Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease The effect of cirrhosis on the disposition and elimination of clindamycin Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs Rate-limiting steps in drug metabolism by microsomes from CCl4-cirrhotic rat liver Influence of binding on drug metabolism and distribution

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software